Episode 2: SAGE Advice

Join us for a conversation about the SAGE-217 phase 2 trial, a new agent under investigation for the treatment of major depressive disorder! We talk about phases of trials, intention to treat vs. per-protocol analysis, and what the heck least mean square differences are. Follow us on Instagram and Twitter @Med_Lit_Review, and share your thoughts! 🔥